REQUEST A DEMO
Total
USD $0.00
Search more companies

Netfarma Ilac Ve Premiks Sanayi Ltd. Sti. (Turkiye)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Netfarma Ilac Ve Premiks Sanayi Limited Sirketi Profile Updated: November 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Netfarma Ilac Ve Premiks Sanayi Ltd. Sti. is a company in Turkiye, with a head office in Istanbul. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was first established on October 27, 2010. It currently has a total number of 18 (2025) employees. In its most recent financial highlights, the company reported a net sales revenue increase of 76.95% in 2024. There was a total growth of 147.36% in Netfarma Ilac Ve Premiks Sanayi Ltd. Sti.’s total assets over the same period. The enterprise’s net profit margin increased by 8.62% in 2024.

Headquarters
Daire:1 No:5 Aydinli Mahallesi Hamam Kuyu Sokak Tuzla
Istanbul; Marmara; Postal Code: 34953

Contact Details: Purchase the Netfarma Ilac Ve Premiks Sanayi Ltd. Sti. report to view the information.

Website: http://www.globalilac.com

Basic Information
Total Employees:
Purchase the Netfarma Ilac Ve Premiks Sanayi Ltd. Sti. report to view the information.
Financial Auditors:
Purchase the Netfarma Ilac Ve Premiks Sanayi Ltd. Sti. report to view the information.
Incorporation Date:
October 27, 2010
Key Executives
Purchase this report to view the information.
Company Manager
Company Performance
Financial values in the chart are available after Netfarma Ilac Ve Premiks Sanayi Ltd. Sti. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
76.95%
Total operating revenue
76.95%
Operating profit (EBIT)
165.82%
Net Profit (Loss) for the Period
4861.47%
Total Assets
147.36%
Total Equity
399.85%
Operating Profit Margin (ROS)
5.96%
Net Profit Margin
8.62%
Return on Equity (ROE)
60.09%
Debt/Equity
-204.13%
Quick Ratio
0.1%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?